MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples